Maria Ourmanova

Title: Maria Ourmanova: Innovator in Hematopoietic Cell Culture

Introduction

Maria Ourmanova is a notable inventor based in Boyds, MD (US). She has made significant contributions to the field of cell biology, particularly in the culture of hematopoietic cells. Her innovative work has implications for medical research and therapeutic applications.

Latest Patents

Maria holds a patent for "Immortalized human stromal cell lines." This patent describes a method for the culture of hematopoietic cells and the production of human cytokines using immortalized human stromal cell lines. The technology enables the maintenance of hematopoietic stem cells' ability to self-replicate and differentiate, as well as the expansion and differentiation of committed progenitors. The patent also includes details about irradiated and non-irradiated immortalized human stromal cells that synthesize various cytokines, including IL-7, IL-8, IL-11, FLT3L, SCF, LIF, M-CSF, TGF-beta 1, GM-CSF, MIP-1alpha, G-CSF, and MCP-1.

Career Highlights

Maria Ourmanova is associated with Human Genome Sciences, Inc., where she has been instrumental in advancing research in her field. Her work has garnered attention for its potential to enhance the understanding of hematopoietic cell behavior and its applications in regenerative medicine.

Collaborations

Maria collaborates with Ruth Wager, who is also a prominent figure in the field. Their partnership exemplifies the importance of teamwork in scientific research and innovation.

Conclusion

Maria Ourmanova's contributions to the field of hematopoietic cell culture through her patent and work at Human Genome Sciences, Inc. highlight her role as an influential inventor. Her innovative methods have the potential to significantly impact medical research and therapeutic practices.